Tonix Pharmaceuticals Holding Corp. (TNXP) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$13.1M

Net Income/Loss (FY2025)

-$124.0M

Total Assets (FY2025)

$277.2M

Total Equity (FY2025)

$245.2M

Cash Flows from Operating Activities (FY2025)

-$99.8M

Source: Tonix Pharmaceuticals Holding Corp. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.